(2R,3S,4R,5S,1R)-4,5-BIS-(TERT.-BUTYLDIMETHYLSILYLOXY)-6-OXABICYCLO-[3.1.0]-HEXAN-1-AMINE
Compound with spectra: 1 NMR
![(2R,3S,4R,5S,1R)-4,5-BIS-(TERT.-BUTYLDIMETHYLSILYLOXY)-6-OXABICYCLO-[3.1.0]-HEXAN-1-AMINE](/api/compound/FOArK7Uodx.png?ph=true&h=300&w=458 "(2R,3S,4R,5S,1R)-4,5-BIS-(TERT.-BUTYLDIMETHYLSILYLOXY)-6-OXABICYCLO-[3.1.0]-HEXAN-1-AMINE")
| SpectraBase Compound ID | FOArK7Uodx |
|---|---|
| InChI | InChI=1S/C17H37NO3Si2/c1-16(2,3)22(7,8)20-13-11(18)12-14(19-12)15(13)21-23(9,10)17(4,5)6/h11-15H,18H2,1-10H3/t11-,12+,13+,14+,15+/m0/s1 |
| InChIKey | BUADWVFADCONAR-NJVJYBDUSA-N |
| Mol Weight | 359.7 g/mol |
| Molecular Formula | C17H37NO3Si2 |
| Exact Mass | 359.231197 g/mol |
| Enantiomer InChIKey | BUADWVFADCONAR-QTVXIADOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1R*,2S*,3S*,5R*,6R*)-3,5-Bis[(tert-butyldimethylsilyl)oxy]-7-oxabicyclo[4.1.0]heptane-2-ol
(1R*,2S*,3R*,5R*,6R*)-3,5-Bis[(tert-butyldimethylsilyl)oxy]-7-oxabicyclo[4.1.0]heptane-2-ol
1,3,4-Tri-O-[tert-butyl(dimethyl)silyl]-5-deoxy-5,5-diiodo-2-O-formyl-D-arabinitol
Methyl 4-O-methyl-pertrimethylsilyl-.alpha.-L-rhamnopyranoside
(-)-(4R,5S,6R)-4,5-BIS-([(TERT.-BUTYL)-DIMETHYLSILYL]-OXY)-6-HYDROXY-CYCLOHEX-2-EN-1-ONE
1-Bromo-1,2,3-trideoxy-4,6-bis-O-(tert-butyldimethylsilyl)-5,7-di-O-ethylidene-D-ribo-hept-1-ynitol
.alpha.-L-Galactopyranoside, methyl 6-deoxy-2,3,4-tris-O-(trimethylsilyl)-
.alpha.-l-Galactofuranoside, methyl 6-deoxy-2,3,5-tris-O-(trimethylsilyl)-
(4S,5R)-4,5-Bis-[(R)-1-(tert-butyl-dimethyl-silanyloxy)-but-3-ynyl]-2,2-dimethyl-[1,3]dioxolane
Methyl 2-O-methyl-pertrimethylsilyl-.alpha.-L-rhamnopyranoside
| Title | Journal or Book | Year |
|---|---|---|
| Total Synthesis of the Hypermodified tRNA Nucleoside Epoxyqueuosine | European Journal of Organic Chemistry | 2013 |